ID   NDF1_HUMAN              Reviewed;         356 AA.
AC   Q13562; B2R9I8; F1T0E1; O00343; Q13340; Q5U095; Q96TH0; Q99455; Q9UEC8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   18-JUN-2025, entry version 218.
DE   RecName: Full=Neurogenic differentiation factor 1;
DE            Short=NeuroD;
DE            Short=NeuroD1;
DE   AltName: Full=Class A basic helix-loop-helix protein 3;
DE            Short=bHLHa3;
GN   Name=NEUROD1; Synonyms=BHLHA3, NEUROD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-45.
RX   PubMed=8786144; DOI=10.1006/geno.1996.0306;
RA   Tamimi R., Steingrimsson E., Copeland N.G., Dyer-Montgomery K., Lee J.E.,
RA   Hernandez R., Jenkins N.A., Tapscott S.J.;
RT   "The NEUROD gene maps to human chromosome 2q32 and mouse chromosome 2.";
RL   Genomics 34:418-421(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-45.
RX   PubMed=8915591; DOI=10.1016/s0169-328x(96)00154-4;
RA   Yokoyama M., Nishi Y., Miyamoto Y., Nakamura M., Akiyama K., Matsubara K.,
RA   Okubo K.;
RT   "Molecular cloning of a human neuroD from a neuroblastoma cell line
RT   specifically expressed in the fetal brain and adult cerebellum.";
RL   Brain Res. Mol. Brain Res. 42:135-139(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-45.
RA   Furuta H., Horikawa Y., Iwasaki N., Hara M., Sussel L., le Beau M.M.,
RA   Davis E.M., Ogata M., Iwamoto Y., German M.S., Bell G.I.;
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-45.
RX   PubMed=10366743; DOI=10.1016/s0169-328x(99)00112-6;
RA   Miyachi T., Maruyama H., Kitamura T., Nakamura S., Kawakami H.;
RT   "Structure and regulation of the human NeuroD (BETA2/BHF1) gene.";
RL   Brain Res. Mol. Brain Res. 69:223-231(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-45.
RA   Noma T.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-45.
RA   Kuroe A., Yamada Y., Kubota A., Someya Y., Iwakura T., Watanabe R.,
RA   Inada A., Miyawaki K., Ban N., Ihara Y., Seino Y.;
RT   "Ala45Thr mutation of the human BETA2 gene.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-45.
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-45.
RX   PubMed=21697133; DOI=10.1167/iovs.11-7479;
RA   Oshikawa M., Tsutsui C., Ikegami T., Fuchida Y., Matsubara M., Toyama S.,
RA   Usami R., Ohtoko K., Kato S.;
RT   "Full-length transcriptome analysis of human retina-derived cell lines
RT   ARPE-19 and Y79 using the vector-capping method.";
RL   Invest. Ophthalmol. Vis. Sci. 52:6662-6670(2011).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-45.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-45.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 88-200.
RC   TISSUE=Retina;
RX   PubMed=9144558; DOI=10.1006/bbrc.1997.6483;
RA   Acharya H.R., Dooley C.M., Thoreson W.B., Ahmad I.;
RT   "cDNA cloning and expression analysis of NeuroD mRNA in human retina.";
RL   Biochem. Biophys. Res. Commun. 233:459-463(1997).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 147-198.
RC   TISSUE=Rhabdomyosarcoma;
RA   Shum C.H., Triche T.J.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   INTERACTION WITH RREB1.
RX   PubMed=12482979; DOI=10.1128/mcb.23.1.259-271.2003;
RA   Ray S.K., Nishitani J., Petry M.W., Fessing M.Y., Leiter A.B.;
RT   "Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene
RT   promoter by the DNA-binding protein Finb/RREB-1.";
RL   Mol. Cell. Biol. 23:259-271(2003).
RN   [16]
RP   INTERACTION WITH NR0B2; EP300 AND TCF3, HETERODIMERIZATION, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=14752053; DOI=10.1210/me.2003-0311;
RA   Kim J.Y., Chu K., Kim H.J., Seong H.A., Park K.C., Sanyal S., Takeda J.,
RA   Ha H., Shong M., Tsai M.J., Choi H.S.;
RT   "Orphan nuclear receptor small heterodimer partner, a novel corepressor for
RT   a basic helix-loop-helix transcription factor BETA2/neuroD.";
RL   Mol. Endocrinol. 18:776-790(2004).
RN   [17]
RP   INVOLVEMENT IN MODY6 AND T2D, AND VARIANT T2D LEU-111.
RX   PubMed=10545951; DOI=10.1038/15500;
RA   Malecki M.T., Jhala U.S., Antonellis A., Fields L., Doria A., Orban T.,
RA   Saad M., Warram J.H., Montminy M., Krolewski A.S.;
RT   "Mutations in NEUROD1 are associated with the development of type 2
RT   diabetes mellitus.";
RL   Nat. Genet. 23:323-328(1999).
RN   [18]
RP   VARIANT MODY6 LYS-110.
RX   PubMed=11719843; DOI=10.1007/s001250100016;
RA   Kristinsson S.Y., Thorolfsdottir E.T., Talseth B., Steingrimsson E.,
RA   Thorsson A.V., Helgason T., Hreidarsson A.B., Arngrimsson R.;
RT   "MODY in Iceland is associated with mutations in HNF-1alpha and a novel
RT   mutation in NeuroD1.";
RL   Diabetologia 44:2098-2103(2001).
RN   [19]
RP   VARIANT ILE-242.
RX   PubMed=25477324; DOI=10.1167/iovs.14-15382;
RA   Wang F., Li H., Xu M., Li H., Zhao L., Yang L., Zaneveld J.E., Wang K.,
RA   Li Y., Sui R., Chen R.;
RT   "A homozygous missense mutation in NEUROD1 is associated with nonsyndromic
RT   autosomal recessive retinitis pigmentosa.";
RL   Invest. Ophthalmol. Vis. Sci. 56:150-155(2015).
RN   [20]
RP   VARIANT MODY6 PRO-103.
RX   PubMed=26773576; DOI=10.1016/j.ejmg.2016.01.002;
RA   Szopa M., Ludwig-Galezowska A.H., Radkowski P., Skupien J., Machlowska J.,
RA   Klupa T., Wolkow P., Borowiec M., Mlynarski W., Malecki M.T.;
RT   "A family with the Arg103Pro mutation in the NEUROD1 gene detected by next-
RT   generation sequencing - Clinical characteristics of mutation carriers.";
RL   Eur. J. Med. Genet. 59:75-79(2016).
CC   -!- FUNCTION: Acts as a transcriptional activator: mediates transcriptional
CC       activation by binding to E box-containing promoter consensus core
CC       sequences 5'-CANNTG-3'. Associates with the p300/CBP transcription
CC       coactivator complex to stimulate transcription of the secretin gene as
CC       well as the gene encoding the cyclin-dependent kinase inhibitor CDKN1A.
CC       Contributes to the regulation of several cell differentiation pathways,
CC       like those that promote the formation of early retinal ganglion cells,
CC       inner ear sensory neurons, granule cells forming either the cerebellum
CC       or the dentate gyrus cell layer of the hippocampus, endocrine islet
CC       cells of the pancreas and enteroendocrine cells of the small intestine.
CC       Together with PAX6 or SIX3, is required for the regulation of amacrine
CC       cell fate specification. Also required for dendrite morphogenesis and
CC       maintenance in the cerebellar cortex. Associates with chromatin to
CC       enhancer regulatory elements in genes encoding key transcriptional
CC       regulators of neurogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:Q60867}.
CC   -!- SUBUNIT: Efficient DNA-binding requires dimerization with another bHLH
CC       protein (By similarity). Heterodimer with TCF3/E47; the heterodimer is
CC       inhibited in presence of ID2, but not NR0B2, to E-box element
CC       (PubMed:14752053). Interacts with EP300; the interaction is inhibited
CC       by NR0B2 (PubMed:14752053). Interacts with RREB1 (PubMed:12482979).
CC       Interacts with ATOH8 (By similarity). {ECO:0000250|UniProtKB:Q60867,
CC       ECO:0000269|PubMed:12482979, ECO:0000269|PubMed:14752053}.
CC   -!- INTERACTION:
CC       Q13562; Q0VDC6: FKBP1A; NbExp=3; IntAct=EBI-3908303, EBI-10226858;
CC       Q13562; P54652: HSPA2; NbExp=3; IntAct=EBI-3908303, EBI-356991;
CC       Q13562; O43464: HTRA2; NbExp=3; IntAct=EBI-3908303, EBI-517086;
CC       Q13562; P42858: HTT; NbExp=6; IntAct=EBI-3908303, EBI-466029;
CC       Q13562; O14901: KLF11; NbExp=3; IntAct=EBI-3908303, EBI-948266;
CC       Q13562; P28331-2: NDUFS1; NbExp=3; IntAct=EBI-3908303, EBI-6190702;
CC       Q13562; Q9BVL2: NUP58; NbExp=3; IntAct=EBI-3908303, EBI-2811583;
CC       Q13562; P41219: PRPH; NbExp=3; IntAct=EBI-3908303, EBI-752074;
CC       Q13562; Q99081-3: TCF12; NbExp=4; IntAct=EBI-3908303, EBI-11952764;
CC       Q13562; P15884-3: TCF4; NbExp=3; IntAct=EBI-3908303, EBI-13636688;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00981, ECO:0000269|PubMed:14752053}.
CC       Note=In pancreatic islet cells, shuttles to the nucleus in response to
CC       glucose stimulation (By similarity). Colocalizes with NR0B2 in the
CC       nucleus. {ECO:0000250}.
CC   -!- PTM: Phosphorylated. In islet cells, phosphorylated on Ser-274 upon
CC       glucose stimulation; which may be required for nuclear localization. In
CC       activated neurons, phosphorylated on Ser-335; which promotes dendritic
CC       growth. Phosphorylated by MAPK1; phosphorylation regulates
CC       heterodimerization and DNA-binding activities. Phosphorylation on Ser-
CC       266 and Ser-274 increases transactivation on the insulin promoter in
CC       glucose-stimulated insulinoma cells (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Maturity-onset diabetes of the young 6 (MODY6) [MIM:606394]: A
CC       form of diabetes that is characterized by an autosomal dominant mode of
CC       inheritance, onset in childhood or early adulthood (usually before 25
CC       years of age), a primary defect in insulin secretion and frequent
CC       insulin-independence at the beginning of the disease.
CC       {ECO:0000269|PubMed:10545951, ECO:0000269|PubMed:11719843,
CC       ECO:0000269|PubMed:26773576}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Type 2 diabetes mellitus (T2D) [MIM:125853]: A multifactorial
CC       disorder of glucose homeostasis caused by a lack of sensitivity to
CC       insulin. Affected individuals usually have an obese body habitus and
CC       manifestations of a metabolic syndrome characterized by diabetes,
CC       insulin resistance, hypertension and hypertriglyceridemia. The disease
CC       results in long-term complications that affect the eyes, kidneys,
CC       nerves, and blood vessels. {ECO:0000269|PubMed:10545951}. Note=Disease
CC       susceptibility is associated with variants affecting the gene
CC       represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U50822; AAA93480.1; -; Genomic_DNA.
DR   EMBL; D82347; BAA11558.1; -; mRNA.
DR   EMBL; AF045152; AAC83145.1; -; Genomic_DNA.
DR   EMBL; AB018693; BAA76603.1; -; Genomic_DNA.
DR   EMBL; AB009997; BAA87605.1; -; Genomic_DNA.
DR   EMBL; AB016079; BAA36519.1; -; Genomic_DNA.
DR   EMBL; BT019731; AAV38536.1; -; mRNA.
DR   EMBL; AK313799; BAG36535.1; -; mRNA.
DR   EMBL; AB593068; BAJ84015.1; -; mRNA.
DR   EMBL; AB593069; BAJ84016.1; -; mRNA.
DR   EMBL; AB593070; BAJ84017.1; -; mRNA.
DR   EMBL; AB593071; BAJ84018.1; -; mRNA.
DR   EMBL; AC013733; AAY24267.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10983.1; -; Genomic_DNA.
DR   EMBL; BC009046; AAH09046.1; -; mRNA.
DR   EMBL; U80578; AAC51318.1; -; mRNA.
DR   EMBL; U36472; AAA79702.1; -; mRNA.
DR   CCDS; CCDS2283.1; -.
DR   RefSeq; NP_002491.3; NM_002500.5.
DR   AlphaFoldDB; Q13562; -.
DR   SMR; Q13562; -.
DR   BioGRID; 110833; 21.
DR   FunCoup; Q13562; 1460.
DR   IntAct; Q13562; 14.
DR   STRING; 9606.ENSP00000295108; -.
DR   CarbonylDB; Q13562; -.
DR   GlyGen; Q13562; 1 site.
DR   iPTMnet; Q13562; -.
DR   PhosphoSitePlus; Q13562; -.
DR   BioMuta; NEUROD1; -.
DR   DMDM; 311033428; -.
DR   jPOST; Q13562; -.
DR   MassIVE; Q13562; -.
DR   PaxDb; 9606-ENSP00000295108; -.
DR   PeptideAtlas; Q13562; -.
DR   Antibodypedia; 922; 536 antibodies from 40 providers.
DR   DNASU; 4760; -.
DR   Ensembl; ENST00000295108.4; ENSP00000295108.3; ENSG00000162992.5.
DR   Ensembl; ENST00000683430.1; ENSP00000506907.1; ENSG00000162992.5.
DR   Ensembl; ENST00000684079.1; ENSP00000507492.1; ENSG00000162992.5.
DR   GeneID; 4760; -.
DR   KEGG; hsa:4760; -.
DR   MANE-Select; ENST00000295108.4; ENSP00000295108.3; NM_002500.5; NP_002491.3.
DR   UCSC; uc002uof.5; human.
DR   AGR; HGNC:7762; -.
DR   CTD; 4760; -.
DR   DisGeNET; 4760; -.
DR   GeneCards; NEUROD1; -.
DR   GeneReviews; NEUROD1; -.
DR   HGNC; HGNC:7762; NEUROD1.
DR   HPA; ENSG00000162992; Group enriched (brain, retina).
DR   MalaCards; NEUROD1; -.
DR   MIM; 125853; phenotype.
DR   MIM; 601724; gene.
DR   MIM; 606394; phenotype.
DR   OpenTargets; ENSG00000162992; -.
DR   Orphanet; 552; MODY.
DR   VEuPathDB; HostDB:ENSG00000162992; -.
DR   eggNOG; KOG3898; Eukaryota.
DR   GeneTree; ENSGT00940000160478; -.
DR   HOGENOM; CLU_055134_0_0_1; -.
DR   InParanoid; Q13562; -.
DR   OMA; SFKHEPA; -.
DR   OrthoDB; 10039134at2759; -.
DR   PAN-GO; Q13562; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q13562; -.
DR   PathwayCommons; Q13562; -.
DR   Reactome; R-HSA-210745; Regulation of gene expression in beta cells.
DR   Reactome; R-HSA-210746; Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells.
DR   SignaLink; Q13562; -.
DR   SIGNOR; Q13562; -.
DR   BioGRID-ORCS; 4760; 9 hits in 1175 CRISPR screens.
DR   GeneWiki; NEUROD1; -.
DR   GenomeRNAi; 4760; -.
DR   Pharos; Q13562; Tbio.
DR   PRO; PR:Q13562; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q13562; protein.
DR   Bgee; ENSG00000162992; Expressed in paraflocculus and 79 other cell types or tissues.
DR   ExpressionAtlas; Q13562; baseline and differential.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IDA:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:BHF-UCL.
DR   GO; GO:0070888; F:E-box binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0035881; P:amacrine cell differentiation; ISS:UniProtKB.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0061564; P:axon development; IBA:GO_Central.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; ISS:UniProtKB.
DR   GO; GO:0021542; P:dentate gyrus development; ISS:UniProtKB.
DR   GO; GO:0048562; P:embryonic organ morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0031018; P:endocrine pancreas development; ISS:UniProtKB.
DR   GO; GO:0035883; P:enteroendocrine cell differentiation; ISS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:BHF-UCL.
DR   GO; GO:0048839; P:inner ear development; ISS:UniProtKB.
DR   GO; GO:0030073; P:insulin secretion; IDA:BHF-UCL.
DR   GO; GO:0046426; P:negative regulation of receptor signaling pathway via JAK-STAT; IEA:Ensembl.
DR   GO; GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0022008; P:neurogenesis; TAS:BHF-UCL.
DR   GO; GO:0003326; P:pancreatic A cell fate commitment; IEA:Ensembl.
DR   GO; GO:0003329; P:pancreatic PP cell fate commitment; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:2000679; P:positive regulation of transcription regulatory region DNA binding; IDA:BHF-UCL.
DR   GO; GO:0050796; P:regulation of insulin secretion; IC:BHF-UCL.
DR   GO; GO:0060730; P:regulation of intestinal epithelial structure maintenance; ISS:UniProtKB.
DR   GO; GO:0009749; P:response to glucose; IMP:BHF-UCL.
DR   GO; GO:0007423; P:sensory organ development; IBA:GO_Central.
DR   GO; GO:0023019; P:signal transduction involved in regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IEA:Ensembl.
DR   CDD; cd19719; bHLH_TS_NeuroD1; 1.
DR   FunFam; 4.10.280.10:FF:000006; Neurogenic differentiation factor; 1.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR050359; bHLH_transcription_factors.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR022575; NeuroD_DUF.
DR   InterPro; IPR016637; TF_bHLH_NeuroD.
DR   PANTHER; PTHR19290; BASIC HELIX-LOOP-HELIX PROTEIN NEUROGENIN-RELATED; 1.
DR   PANTHER; PTHR19290:SF88; NEUROGENIC DIFFERENTIATION FACTOR 1; 1.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF12533; Neuro_bHLH; 1.
DR   PIRSF; PIRSF015618; bHLH_NeuroD; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   neXtProt; NX_Q13562; -.
DR   PharmGKB; PA31564; -.
DR   TreeFam; TF315153; -.
PE   1: Evidence at protein level;
KW   Activator; Cytoplasm; Developmental protein; Diabetes mellitus;
KW   Differentiation; Disease variant; DNA-binding; Neurogenesis; Nucleus;
KW   Phosphoprotein; Proteomics identification; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..356
FT                   /note="Neurogenic differentiation factor 1"
FT                   /id="PRO_0000127381"
FT   DOMAIN          101..153
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   REGION          1..94
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           87..93
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        58..78
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        81..93
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60867"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60867"
FT   MOD_RES         266
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60867"
FT   MOD_RES         274
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60867"
FT   MOD_RES         335
FT                   /note="Phosphoserine; by CaMK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q64289"
FT   VARIANT         45
FT                   /note="T -> A (in dbSNP:rs1801262)"
FT                   /evidence="ECO:0000269|PubMed:10366743,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:21697133, ECO:0000269|PubMed:8786144,
FT                   ECO:0000269|PubMed:8915591, ECO:0000269|Ref.11,
FT                   ECO:0000269|Ref.3, ECO:0000269|Ref.5, ECO:0000269|Ref.6"
FT                   /id="VAR_014820"
FT   VARIANT         103
FT                   /note="R -> P (in MODY6)"
FT                   /evidence="ECO:0000269|PubMed:26773576"
FT                   /id="VAR_076552"
FT   VARIANT         110
FT                   /note="E -> K (in MODY6; uncertain significance;
FT                   dbSNP:rs763092306)"
FT                   /evidence="ECO:0000269|PubMed:11719843"
FT                   /id="VAR_076553"
FT   VARIANT         111
FT                   /note="R -> L (in T2D; dbSNP:rs104893649)"
FT                   /evidence="ECO:0000269|PubMed:10545951"
FT                   /id="VAR_012487"
FT   VARIANT         197
FT                   /note="P -> H (in dbSNP:rs8192556)"
FT                   /id="VAR_031260"
FT   VARIANT         242
FT                   /note="V -> I (found in one consanguineous family with
FT                   non-syndromic autosomal recessive retinitis pigmentosa;
FT                   uncertain significance; dbSNP:rs786205158)"
FT                   /evidence="ECO:0000269|PubMed:25477324"
FT                   /id="VAR_076554"
FT   CONFLICT        157
FT                   /note="L -> S (in Ref. 1; AAA93480)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        185
FT                   /note="A -> G (in Ref. 2; BAA11558 and 5; BAA87605)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        232
FT                   /note="G -> D (in Ref. 6; BAA36519)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   356 AA;  39920 MW;  B78075D1CF66E943 CRC64;
     MTKSYSESGL MGEPQPQGPP SWTDECLSSQ DEEHEADKKE DDLETMNAEE DSLRNGGEEE
     DEDEDLEEEE EEEEEDDDQK PKRRGPKKKK MTKARLERFK LRRMKANARE RNRMHGLNAA
     LDNLRKVVPC YSKTQKLSKI ETLRLAKNYI WALSEILRSG KSPDLVSFVQ TLCKGLSQPT
     TNLVAGCLQL NPRTFLPEQN QDMPPHLPTA SASFPVHPYS YQSPGLPSPP YGTMDSSHVF
     HVKPPPHAYS AALEPFFESP LTDCTSPSFD GPLSPPLSIN GNFSFKHEPS AEFEKNYAFT
     MHYPAATLAG AQSHGSIFSG TAAPRCEIPI DNIMSFDSHS HHERVMSAQL NAIFHD
//
